Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 1 / Phase 2 | 2026-01-13 | NCT07333469 | |
| HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies | Advanced Solid Tumor Malignancies | Recruiting | Phase 1 / Phase 2 | 2025-01-14 | NCT06649708 |